Boosh to Introduce 2 New Frozen Boosh Bowls, One Refrigerated Heat n' Eat Pouch In Q1

Boosh to Introduce 2 New Frozen Boosh Bowls, One Refrigerated Heat n' Eat Pouch In Q1

Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh" or the "Company") is pleased to announce that it will be introducing three new dishes In the first quarter of 2022.

Two new frozen entrees include a convenient heat n' eat Boosh Breakfast Bowl and Buddha Bowl. Ingredients for the breakfast bowl include potato vegetable hash, vegan sausage crumble and scrambled tofu "eggs". The Buddha Bowl ingredients include our proprietary non-GMO organic rice blend with a miso tahini sauce, a variety of fresh and roasted veggies, fresh edamame and lupin bean grits.

The new refrigerated item is Sweet n' Sour "Chicken", which is suggested to be served over a bed of rice or noodles. The dish includes a delicious tangy sauce with broccoli, carrots, mushrooms, onions and peppers and a great new vegan "chicken" (which we source locally) that tastes and looks like dark chicken meat.

"Lupin beans are the latest craze in plant-based eating because they have about a third more protein per square inch than many other beans and legumes. Plus, they have practically no starch, so they won't spike your blood sugar, and will stave off hunger," states Boosh Founder and President Connie Marples.

Connie continues, "Our research and development team along with our consulting chefs are working on new products to launch in the first half of 2022. At any given time, we have approximately twenty different items in various stages of experimentation. We are constantly analyzing the marketplace to anticipate what consumers will want next. Several years ago, consumers were content with having various types of plant-based "meat" dishes to enjoy as burgers. Today consumers want more new and exciting entrees, which Boosh is constantly providing. We want to make it easy for people to transition to a more plant-based diet, and as a result we'll continue to add to our growing line of innovative, healthy family-oriented plant-based meals."

Boosh is combining its research, analysis, and its empirical data that is generated from a sales prospective with the research and development created by our chefs on new products to increase the likelihood of success in the marketplace.

On behalf of the Board of Directors

Jim Pakulis
Chief Executive Officer

Telephone: (833) 882-6674

www.Booshfood.com

About Boosh Plant-Based Brands Inc.:

Boosh Plant-Based Brands Inc., through its wholly owned subsidiary, Boosh Food (www.booshfood.com), offers high quality, non-GMO, gluten free, 100% plant-based nutritional comfort foods for the whole family. We currently offer 24 plant-based SKU's ranging from frozen meals, to refrigerated entrees to shelf stable Mac & Cheezes, and are sold throughout Canada. Boosh, good for you and good for planet earth.

The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Forward-looking statements in this news release include, but are not limited to, the Company's proposed use of the proceeds of its initial public offering. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/108608

News Provided by Newsfile via QuoteMedia

VEGI:CC
The Conversation (0)
Boosh Hires Pixie Brands and Multi Brands Sampling Co for BC Promos and Store Sampling

Boosh Hires Pixie Brands and Multi Brands Sampling Co for BC Promos and Store Sampling

Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh" or the "Company"), a premier plant-based brand in the "better for you" food sector, announced today it is working with Pixie Brands @meetpixiebrands and Multi Brand Sampling Co @multibrandsmaplingco to promote and enhance sales at store level for all Boosh and Beanfields brands in BC.

Founded by CPG founder April Angelini, Pixie Brands offers a relationship-based, boots on the ground approach to help small and medium brands SHINE. They offer sales and distributor support and organize In-Store Events.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Boosh Expands into United Sates Hospitality Services Sector

Boosh Expands into United Sates Hospitality Services Sector

Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77i) ("Boosh" or the "Company") a premier plant-based brand in the "better for you" food sector announced today it has begun production of 1.5 oz bags of Beanfields Chips to open up sales to the US hospitality sector. Beanfields Snacks, the primary asset of Boosh Plant Based Brands, represents a significant growth opportunity in the salty snacks sector.

Prior to Boosh Plant-Based Brands acquiring the asset Beanfields Chips, the previous owners had made inroads into the hospitality sector with accounts at Universities, Corporate offices and numerous independent quick serve and convenience stores representing annual sales of $1.7M CAN.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Boosh Announces Shares for Debt Transaction

Boosh Announces Shares for Debt Transaction

Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77i) ("Boosh" or the "Company") a premier plant-based brand in the "better for you" food sector announced today that it had entered into, and that it had finalized a secondary set of debt settlement agreements with the purpose to both satisfy and to extinguish an aggregate total of C$722,710 of secured debts. A combined total of 16,060,207 common shares were issued at a deemed price of C$0.045 per common share.

The Company decided to satisfy the indebtedness with common shares to preserve its cash for the development of its business. No new control person of the Company will be created pursuant to the settlement of the debt settlement agreements.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Boosh Plant-Based Brands Inc. Announces Engagement with Storied Health Partners and Debt Settlement

Boosh Plant-Based Brands Inc. Announces Engagement with Storied Health Partners and Debt Settlement

Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77i) ("Boosh" or the "Company"), a premier plant-based brand in the "better for you" food sector, is pleased to announce that it has engaged Storied Health Partners, a resource-rich platform that provides entrepreneurs the support and leverage they need to maximize their growth potential and accomplish their brand's next milestone.

CEO of Storied Health Partners, Anis Barakat, is a food and beverage expert with nearly a decade of experience in senior leadership roles in the industry. Mr. Barakat is the founder and former President of Revive Superfoods, the first multi-national frozen superfood subscription company selling ready-to-eat/blend meals such as smoothies, oats, soups and lunch/dinner bowls direct-to-consumer throughout the United States, Canada and UAE. During his time with Revive Superfoods, Anis was instrumental in developing a highly scalable direct-to-consumer ("DTC") subscription model that disrupted the ready-meal industry and achieved incredible success since its inception in 2018.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
CORRECTION FROM SOURCE: Correction of the Press Releases Dated January 9, 2023 and March 14, 2023

CORRECTION FROM SOURCE: Correction of the Press Releases Dated January 9, 2023 and March 14, 2023

Boosh Plant-Based Brands Inc. (CSE: VEGI) (OTCQB: VGGIF) (FSE: 77I) ("Boosh" or the "Company"), a premier plant-based brand in the "better for you" food sector, issues the following corrected press release to the press releases dated January 9, 2023 and March 14, 2023 concerning the completion of a non-brokered private placement for gross proceeds of $362,000.

The corrections are being made to correct and restate the terms of the previously announced non-brokered private placement.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Genes and chromosomes with "2024" overlay.

Biotech Market Update: Q1 2024 in Review

The first quarter of 2024 witnessed a surge in initial public offerings (IPOs) and mergers and acquisitions (M&A) within the biotech industry, signaling continued interest from investors.

AstraZeneca’s acquisition of start-up Amolyt on March 14, and its longtime biotech partner Fusion Pharmaceuticals for US$2.4 billion on March 19 marked the third acquisition of a radiopharmaceutical developer in recent months. As of writing, there have been 14 M&A deals struck in 2024, according to data from Biopharma Dive.

Investment bank Jefferies released data in early March revealing that the sector was on track to earn its highest quarterly total in three years, reflecting the cautiously optimistic outlook at this year's JPM24 conference.

Keep reading...Show less

AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024

Planning Underway for Phase 3 Development of Tezepelumab in COPD

Amgen (NASDAQ:AMGN) today provided an update regarding the results of the Phase 2a COURSE trial for TEZSPIRE ® (tezepelumab-ekko) in chronic obstructive pulmonary disease (COPD), which were accepted for presentation in the Clinical Trials Symposium at The American Thoracic Society (ATS) 2024 International Conference on Monday, May 20 from 9:15-11:15 a.m. PDT .

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
Close up 3D rendering of DNA strands.

Biotech Stocks: 5 Biggest Companies in 2024

What are the top biotech companies? The following five stocks have market capitalizations worth billions of dollars and operate in countries all around the globe.

Plus, these big-name biotech players have pipelines stuffed with potentially disruptive products — and enough revenue to recover should some of those products fail.

This means that investors can experience the excitement of biotech investing while minimizing risk. Although returns are never guaranteed, company size can insulate investors from volatility.

Keep reading...Show less
SIRONA BIOCHEM Corporate Update April 2024

SIRONA BIOCHEM Corporate Update April 2024

Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (" Sirona " or the " Company ") provides the following update:

Dear shareholders,

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Sirona Biochem Announces Close of Private Placement

Sirona Biochem Announces Close of Private Placement

Vancouver, British Columbia – April 4, 2024 Sirona Biochem Corp . (TSX-V: SBM) (Frankfurt: ZSB) (" Sirona ") has closed its private placement (Private Placement") for gross proceeds of $132,500 CAD. The Private Placement consists of 1,325,000 units, (the "Units") at a price of $0.10 per Unit. Each Unit consists of one common share and one transferable share purchase warrant, each whole warrant exercisable into one additional common share of the Company for a period of 2 years from the date of issue at a price of $0.15 per Share in year one and $0.25 per Share in year two. All securities issued under the Private Placement are subject to statutory hold periods expiring on August 4, 2024.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Need injecting into red and white cell.

How to Invest in Biotechnology (Updated 2024)

Investors interested in the life science sector are well aware of the importance of biotechnology.

From finding cures for diseases to feeding future generations, many areas of day-to-day life are influenced by players in the biotechnology space, and expert projections show the industry's future looks bright.

But how can investors gain exposure to biotechnology? Here’s a brief overview of how to invest in the expanding biotechnology market, from stocks to watch to exchange-traded funds (ETFs).

Keep reading...Show less

Latest Press Releases

Related News

×